NASDAQ:ONTX - Onconova Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$3.30 +0.10 (+3.13 %)
(As of 02/19/2019 04:19 AM ET)
Previous Close$3.20
Today's Range$3.1920 - $3.49
52-Week Range$1.69 - $20.85
Volume38,464 shs
Average Volume170,306 shs
Market Capitalization$18.72 million
P/E Ratio-0.08
Dividend YieldN/A
Beta2.53

Analyst Ratings

Onconova Therapeutics (NASDAQ:ONTX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Onconova Therapeutics in the last 12 months. Their average twelve-month price target is $20.50, suggesting that the stock has a possible upside of 521.21%. The high price target for ONTX is $25.00 and the low price target for ONTX is $16.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $20.50$20.50$20.50$45.00
Price Target Upside: 521.21% upside420.30% upside390.43% upside631.71% upside

Onconova Therapeutics (NASDAQ:ONTX) Consensus Price Target History

Price Target History for Onconova Therapeutics (NASDAQ:ONTX)

Onconova Therapeutics (NASDAQ:ONTX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/8/2019HC WainwrightReiterated RatingBuy$25.00LowView Rating Details
12/3/2018Maxim GroupSet Price TargetBuy$16.00HighView Rating Details
7/25/2017Dawson JamesReiterated RatingBuyHighView Rating Details
4/27/2017LaidlawInitiated CoverageBuy ➝ Buy$150.00LowView Rating Details
(Data available from 2/19/2017 forward)
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Featured Article: Capital Gains

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel